Rapid Urease Test Procedure, Principle, and Results

The Rapid Urease Test (RUT), also known as the Campylobacter-like organism test, is a swift and reliable tool for diagnosing Helicobacter pylori.

Helicobacter pylori, a spiral-shaped bacterium residing in the gastric mucosa, has been implicated as a major player in various gastrointestinal disorders, ranging from gastritis and peptic ulcers to gastric cancer. 

Rapid Urease Test principle

As H. pylori colonizes the gastric mucosa and secretes urease, the enzymatic activity triggers a sequence of events crucial for detecting the infection. A test biopsy is placed in a medium containing urea and an indicator. The urease enzyme produced by H. pylori catalyzes the conversion of urea to ammonia. As a result, the pH of the medium increases, leading to a distinct color change in the indicator. This change, from yellow (NEGATIVE) to red (POSITIVE), serves as a direct visual confirmation of the presence of H. pylori.

The urease enzyme catalyzes the hydrolysis of urea, a compound abundant in gastric juices, into ammonia and carbon dioxide. This process serves a dual purpose for the bacterium. First, ammonia production creates a microenvironment around H. pylori that is less acidic, allowing it to thrive in an otherwise hostile milieu. Second, the ammonia produced can neutralize stomach acid in the immediate vicinity, providing a protective buffer for H. pylori.

The urease enzyme contributes to the pathogenesis of H. pylori-associated diseases. The release of ammonia and other byproducts during urea hydrolysis can induce local inflammation and damage to the gastric epithelium, paving the way for developing conditions such as gastritis and peptic ulcers.

In essence, the RUT exploits the urease activity of H. pylori as a specific and rapid marker for infection. 

Rapid Urease Test Procedure

1. Begin by performing a gastroscopy inserting a flexible endoscope into the stomach.
2. Collect a biopsy specimen from the antrum of the stomach during the gastroscopy.

3. Quickly transfer the biopsy specimen into a prepared specialized medium. This medium contains urea as a substrate and an indicator, such as phenol red.

4. Allow the biopsy specimen to interact with the urease enzyme secreted by H. pylori in the medium.

5. The urease enzyme catalyzes the hydrolysis of urea into ammonia and carbon dioxide.

6. Recognize that the produced ammonia acts as a pH modulator in the medium. The acidic stomach environment undergoes a noticeable rise in pH due to the enzymatic reaction.

7. Observe the indicator, usually phenol red, undergo a visible color change in response to the pH modulation. A change from yellow (NEGATIVE) to red (POSITIVE) indicates the presence of H. pylori.

8. A positive result signifies the presence of H. pylori, while a negative result indicates its absence in the biopsy specimen.

9. Document the results in the patient’s medical records.

Types of Rapid Urease Test 

1. Single-layer RUT:

The Single-layer Rapid Urease Test (RUT) features a diagnostic element impregnated with urea and an indicator composition. This design allows for a straightforward and rapid assessment of Helicobacter pylori activity during gastroscopy. However, its simplicity is accompanied by a susceptibility to false-positive results due to factors like variations in gastric pH, stemming from salivation, bile reflux, or medication use.

2. Selective Urease Test:

The Selective Urease Test represents an evolution in RUT design, incorporating multiple layers to enhance accuracy. The biopsy sample is initially placed on a layer impregnated with urea, initiating the enzymatic reaction. Ammonia formed during this process traverses a selective membrane to reach a second layer impregnated with the indicator. This separation of enzymatic and indicator reactions minimizes the impact of extraneous factors on the diagnostic outcome, resulting in increased sensitivity and specificity.

Related: H pylori Kit: Side Effects, Dosage, Composition, and Pricing 

Limitations of The Rapid Urease Test (RUT) 

1. Proton Pump Inhibitors (PPIs): The accuracy of the RUT may be influenced by the use of proton pump inhibitors (PPIs), medications commonly prescribed to reduce stomach acid. PPIs can affect the location of Helicobacter pylori in the stomach, potentially impacting the biopsy site during gastroscopy.

2. Active Gastrointestinal Bleeding: In cases of active gastrointestinal bleeding, blood can interfere with the enzymatic reactions and color changes essential for the RUT. Hemoglobin from the blood may alter the pH of the biopsy specimen, leading to potential false-negative or inconclusive results.

3. Specific Clinical Scenarios: The test’s interpretation should be cautiously approached in specific clinical scenarios. Factors such as excessive salivation, alkaline bile reflux, and medications that alter stomach acidity can influence the pH of the biopsy specimen, leading to false-positive results.

Alternative Diagnostic Methods

1. Urea Breath Test (UBT):

A non-invasive test where the patient ingests a special urea solution labeled with a specific isotope. If H. pylori is present, it metabolizes the urea, releasing labeled carbon dioxide, which is detected in the patient’s breath.

2. Serology:

Blood tests that measure the presence of antibodies produced by the immune system in response to H. pylori infection. While convenient, they indicate past or present infection and may yield false positives or negatives.

3. Stool Antigen Test (SAT):

Detects H. pylori antigens in stool samples. It is non-invasive and can help monitor treatment success or identify reinfection.

4. Histology:

It involves examining a biopsy sample under a microscope to detect the presence of H. pylori bacteria. Histology is commonly performed during gastroscopy.

5. Culture:

The isolation of H. pylori from biopsy specimens and its subsequent growth in a culture medium. While accurate, it is time-consuming and requires specialized laboratory facilities.

6. PCR (Polymerase Chain Reaction):

A molecular technique that amplifies and detects specific DNA sequences of H. pylori. PCR is highly sensitive and can provide information about bacterial strains.

7. Endoscopic Tests:

In addition to biopsy-based tests, endoscopic techniques, such as confocal laser endomicroscopy, can aid in visualizing H. pylori-related changes in the stomach lining.

Conclusion

The Rapid Urease Test harnesses the enzymatic prowess of H. pylori’s urease, coupled with a visual indicator, providing a rapid and reliable means of identifying bacterial presence during gastroscopy. While the RUT boasts high specificity and sensitivity, its limitations, notably influenced by proton pump inhibitors and active gastrointestinal bleeding, necessitate careful interpretation of results. 

As we navigate the complexities of H. pylori diagnostics, the Rapid Urease Test, with its advantages and considerations, stands as a vital ally in pursuing timely and precise patient care, offering insights into the intricate interplay between bacterial enzymology and diagnostic science.